Victoza

 

Topic mentions per year

Topic mentions per year

2009-2017
051020092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Victoza (liraglutide) is a modern antidiabetic drug of GLP1 (glucagone like peptide) analogue group; since 2009 registered in… (More)
Is this relevant?
2014
Highly Cited
2011
Highly Cited
2011
Type 2 diabetes is a risk factor for Alzheimer's disease (AD), most likely linked to an impairment of insulin signalling in the… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
One of the symptoms of diabetes is the progressive development of neuropathies. One mechanism to replace neurons in the CNS is… (More)
Is this relevant?
2011
2011
The glucagon-like-peptide-1 receptor (GLP-1R) agonists, liraglutide (Victoza) and the synthetic product of exendin-4 (Byetta… (More)
Is this relevant?
2010
2010
  • The Medical letter on drugs and therapeutics
  • 2010
Liraglutide (Victoza-Novo Nordisk), a glucagon-like peptide-1 (GLP-1) receptor agonist given by subcutaneous injection, has been… (More)
Is this relevant?
2010
2010
Type 2 diabetes has been identified as a risk factor for patients with Alzheimer's disease. Insulin signalling is often impaired… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 3
Is this relevant?
2010
2010
Liraglutide (Victoza) is a peptide produced by DNA recombinant technology, which presents 97% homology with human glucagon-like… (More)
Is this relevant?
2010
2010
  • 2010
WARNING: RISK OF THYROID C-CELL TUMORS See full prescribing information for complete boxed warning. • Liraglutide causes thyroid… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2010
2010
  • 2010
498 P&T® • September 2010 • Vol. 35 No. 9 INTRODUCTION According to the Centers for Disease Control and Prevention (CDC… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?